Todd Watanabe - Reporting Person's title: President and Chief Executive Officer, Director at Arcutis Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Reporting Person's title: President and Chief Executive Officer, Director
Issuer Symbol: ARQT on Nasdaq
All Insider Reports: All Insider Reports

Todd Watanabe - trading volume in the past year for Arcutis Biotherapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-228,858	100%	$21.25	-$4,863,151
Net	-228,858	-100%		-$4,863,151

Holdings reported by Todd Watanabe for Arcutis Biotherapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	740,537	$22,479,444	$30.36	24 Nov 2025	Direct
Common Stock	124,956	$2,609,081	$20.88	21 Nov 2025	By Trust
Common Stock	57,358	$1,197,635	$20.88	21 Nov 2025	By LLC
Stock Option (right to buy)	396,000			28 Feb 2025	Direct	Common Stock

Transactions reported by Todd Watanabe for Arcutis Biotherapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.